A-112

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameA-112
Drug Alias Nametamibarotene analog (Shandong University)A-112
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptors agonists
TargetsRetinoic acid receptors
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShandong University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShandong University
Active IndicationsN/A
Inactive IndicationsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A